NUVATION BIO INC (NUVB) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:NUVB • US67080N1019
5.7 USD
+0.08 (+1.42%)
At close: Feb 6, 2026
5.68 USD
-0.02 (-0.35%)
After Hours: 2/6/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 84% to NUVB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 11.42. This target is 100.42% above the current price.
- NUVB was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NUVB.
- In the previous month the buy percentage consensus was at a similar level.
- NUVB was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | UBS | Initiate | Neutral |
| 2025-12-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-20 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-19 | B. Riley Securities | Initiate | Buy |
| 2025-11-04 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-09-30 | Jefferies | Initiate | Buy |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-25 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-23 | JMP Securities | Initiate | Market Outperform |
| 2025-03-12 | Jones Trading | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
NUVATION BIO INC / NUVB FAQ
What is the average price target for NUVATION BIO INC (NUVB) stock?
16 analysts have analysed NUVB and the average price target is 11.42 USD. This implies a price increase of 100.42% is expected in the next year compared to the current price of 5.7.
How do analysts rate NUVATION BIO INC (NUVB)?
The consensus rating for NUVATION BIO INC (NUVB) is 83.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.